Clinical Trials in Ohio

Showing 9101-9120 of 20,938 trials

HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation

NCT05409378

To evaluate the safety and performance of The Meridian® TAVR Valve in patients with severe aortic regurgitation who present at high risk for aortic valve replacement surgery.

Aortic Regurgitation

HLT Inc.Started Jul 2022

Chicago, Illinois, United States • Cincinnati, Ohio, United States • Columbus, Ohio, United States

TERMINATEDPhase 378 miles

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

NCT02245568

The purpose of this study is to provide subjects who have completed participation in a Phase 2 or Phase 3 trial of LMTM continued access to therapy and to evaluate the long-term safety of LMTM.

Alzheimer's DiseaseBehavioral Variant Frontotemporal Dementia

TauRx Therapeutics Ltd913 participantsStarted Aug 2014

Phoenix, Arizona, United States • Fountain Valley, California, United States • Laguna Hills, California, United States +132 more locations

HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Find Trials by Condition in Ohio

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's Disease

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

AllyQuest Adherence App Intervention for HIV-positive Men Who Have Sex With Men and Transgender Women: Pilot Trial

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Study of Diroximel Fumarate in the Real-World Setting

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Aligning Medications With What Matters Most

Implementing Personal Health Records to Promote Evidence-Based Cancer Screening

A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control Participants

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer

Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)